The proposal that replication of human immunodeficiency virus type 1 (HIV-1), mediated by cell-to-cell transmission of the virus, might bypass de novo reverse transcription was tested by using one-step cell-to-cell and cell-free virus infection systems. Two well characterized reverse transcriptase (RT) inhibitors, azidothymidine at 20 µm and phosphonoformic acid at 100 µg/ml, blocked HIV replication completely following both cell-free virus and cell-to-cell transmission infection, as determined from the kinetics of unintegrated viral DNA synthesis and supernatant RT production after virus infection. Our results confirm that de novo reverse transcription is a crucial and mandatory event in HIV-1 replication following cell-to-cell transmission of the virus.
BukrinskyM. I.,
StanwickT. L.,
DempseyM. P.,
StevensonM.1991; Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423–427
DietzscholdB.,
WiktorT. J.,
TrojanowskiJ. Q.,
MacFarlanR. I.,
WunnerW. H.,
Torres-AnjelM. J.,
KoprowskiH.1985; Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro
. Journal of Virology 56:12–18
GuptaP.,
BalachandranR.,
HoM.,
EnricoA.,
RinaldoC.1989; Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. Journal of Virology 63:2361–2365
HahnB. H.,
ShawG. M.,
AryaS. K.,
PopovicM.,
GalloR. C.,
Wong-StaalF.1984; Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature, London 312:166–169
HoffmanA. D.,
BanapourB.,
LevyJ. A.1985; Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326–335
HooksJ. J.,
BurnsW.,
HayashiK.,
GeisS.,
NotkinsA. L.1976; Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection. Infection and Immunity 14:1172–1178
LiP.,
BurrellC. J.1991; Synthesis of human immunodeficiency virus DNA in a cell-to-cell transmission model. AIDS Research and Human Retroviruses (in press)
NakashimaH.,
MatsuiT.,
HaradaS.,
KobayashiN.,
MatsudaA.,
UedaT.,
YamamotoN.1986; Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/ lymphadenopathy-associated virus by 3′-azido-3′-deoxythymidine in vitro
. Antimicrobial Agents and Chemotherapy 30:933–937
PietroboniG. R.,
HarnettG. B.,
BucensM. R.1989; Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro
. Journal of Virological Methods 24:85–90
SmithM. S.,
BrianE. L.,
PaganoJ. S.1987; Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine. Journal of Virology 61:3769–3773
WondrakE. M.,
LowerJ.,
KurthR.1988; Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs. Journal of Antimicrobial Chemotherapy 21:151–161